In this regard, CYP8B1 knockdown in rodent models of NAFLD significantly lowered hepatic lipid content [25,26], which suggests that a decrease in CYP8B1 expression may protect against NAFLD. Here, CYP8B1 is linked to metabolic dysfunction-associated steatotic liver disease.